206 related articles for article (PubMed ID: 36920905)
21. Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastoma.
Parker JJ; Dionne KR; Massarwa R; Klaassen M; Foreman NK; Niswander L; Canoll P; Kleinschmidt-Demasters BK; Waziri A
Neuro Oncol; 2013 Aug; 15(8):1048-57. PubMed ID: 23749785
[TBL] [Abstract][Full Text] [Related]
22. Analysis of EGFR gene amplification, protein over-expression and tyrosine kinase domain mutation in recurrent glioblastoma.
Toth J; Egervari K; Klekner A; Bognar L; Szanto J; Nemes Z; Szollosi Z
Pathol Oncol Res; 2009 Jun; 15(2):225-9. PubMed ID: 18752056
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Biomarker Assays for
Lassman AB; Roberts-Rapp L; Sokolova I; Song M; Pestova E; Kular R; Mullen C; Zha Z; Lu X; Gomez E; Bhathena A; Maag D; Kumthekar P; Gan HK; Scott AM; Guseva M; Holen KD; Ansell PJ; van den Bent MJ
Clin Cancer Res; 2019 Jun; 25(11):3259-3265. PubMed ID: 30796037
[TBL] [Abstract][Full Text] [Related]
24. Rapid detection of high-level oncogene amplifications in ultrasonic surgical aspirations of brain tumors.
Truong LN; Patil S; Martin SS; LeBlanc JF; Nanda A; Nordberg ML; Beckner ME
Diagn Pathol; 2012 Jun; 7():66. PubMed ID: 22691727
[TBL] [Abstract][Full Text] [Related]
25. Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ.
Schulte A; Liffers K; Kathagen A; Riethdorf S; Zapf S; Merlo A; Kolbe K; Westphal M; Lamszus K
Neuro Oncol; 2013 Oct; 15(10):1289-301. PubMed ID: 23877316
[TBL] [Abstract][Full Text] [Related]
26. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
[TBL] [Abstract][Full Text] [Related]
27. Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment.
Sidorov M; Dighe P; Woo RWL; Rodriguez-Brotons A; Chen M; Ice RJ; Vaquero E; Jian D; Desprez PY; Nosrati M; Galvez L; Leng L; Dickinson L; Kashani-Sabet M; McAllister SD; Soroceanu L
Cells; 2023 Feb; 12(4):. PubMed ID: 36831214
[TBL] [Abstract][Full Text] [Related]
28. A clinicopathological and molecular analysis of glioblastoma multiforme with long-term survival.
Das P; Puri T; Jha P; Pathak P; Joshi N; Suri V; Sharma MC; Sharma BS; Mahapatra AK; Suri A; Sarkar C
J Clin Neurosci; 2011 Jan; 18(1):66-70. PubMed ID: 20888234
[TBL] [Abstract][Full Text] [Related]
29. Practical Bioinformatic DNA-Sequencing Pipeline for Detecting Oncogene Amplification and EGFRvIII Mutational Status in Clinical Glioblastoma Samples.
Miller ML; Tome-Garcia J; Waluszko A; Sidorenko T; Kumar C; Ye F; Tsankova NM
J Mol Diagn; 2019 May; 21(3):514-524. PubMed ID: 31000415
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic implication of alterations in epidermal growth factor receptor and MGMT in glioblastoma].
Zhang LY; Ge HJ; Wang LM; Zhao LH; Liu L; Zhang DJ; Cai YN; Lu DH; Piao YS
Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):186-191. PubMed ID: 30831643
[No Abstract] [Full Text] [Related]
31. EGFR/CEP7 high polysomy is separate and distinct from EGFR amplification in glioblastoma as determined by fluorescence in situ hybridization.
Wilcock DM; Goold E; Zuromski LM; Davidson C; Mao Q; Sirohi D
J Neuropathol Exp Neurol; 2024 Apr; 83(5):338-344. PubMed ID: 38605523
[TBL] [Abstract][Full Text] [Related]
32. Glioblastomas in the older old.
Kleinschmidt-DeMasters BK; Lillehei KO; Varella-Garcia M
Arch Pathol Lab Med; 2005 May; 129(5):624-31. PubMed ID: 15859633
[TBL] [Abstract][Full Text] [Related]
33. Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer.
Sitthideatphaiboon P; Teerapakpinyo C; Korphaisarn K; Leelayuwatanakul N; Pornpatrananrak N; Poungvarin N; Chantranuwat P; Shuangshoti S; Aporntewan C; Chintanapakdee W; Sriuranpong V; Vinayanuwattikun C
Sci Rep; 2022 Feb; 12(1):2167. PubMed ID: 35140316
[TBL] [Abstract][Full Text] [Related]
34. Molecular pathologic diagnosis of epidermal growth factor receptor.
Maire CL; Ligon KL
Neuro Oncol; 2014 Oct; 16 Suppl 8(Suppl 8):viii1-6. PubMed ID: 25342599
[TBL] [Abstract][Full Text] [Related]
35. Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma.
Pinheiro KV; Thomaz A; Souza BK; Metcalfe VA; Freire NH; Brunetto AT; de Farias CB; Jaeger M; Bambini V; Smith CGS; Shaw L; Roesler R
Mol Biol Rep; 2020 Sep; 47(9):6817-6828. PubMed ID: 32862352
[TBL] [Abstract][Full Text] [Related]
36. Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.
Giannini C; Sarkaria JN; Saito A; Uhm JH; Galanis E; Carlson BL; Schroeder MA; James CD
Neuro Oncol; 2005 Apr; 7(2):164-76. PubMed ID: 15831234
[TBL] [Abstract][Full Text] [Related]
37. High level EGFR amplification in a newly established glioblastoma cell line 170-MG-BA.
MacLeod RAF; Schneider B; Sivakova I; Nagel S; Dirks WG; Mraz P; Kubikova E; Perzelova A
Neoplasma; 2019 Jan; 66(1):109-117. PubMed ID: 30509096
[TBL] [Abstract][Full Text] [Related]
38. Whole genome sequence analysis links chromothripsis to EGFR, MDM2, MDM4, and CDK4 amplification in glioblastoma.
Furgason JM; Koncar RF; Michelhaugh SK; Sarkar FH; Mittal S; Sloan AE; Barnholtz-Sloan JS; Bahassi el M
Oncoscience; 2015; 2(7):618-28. PubMed ID: 26328271
[TBL] [Abstract][Full Text] [Related]
39. Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme.
Hayashi Y; Ueki K; Waha A; Wiestler OD; Louis DN; von Deimling A
Brain Pathol; 1997 Jul; 7(3):871-5. PubMed ID: 9217972
[TBL] [Abstract][Full Text] [Related]
40. Establishment and partial characterization of five malignant glioma cell lines.
Zhang L; Yamane T; Satoh E; Amagasaki K; Kawataki T; Asahara T; Furuya K; Nukui H; Naganuma H
Neuropathology; 2005 Jun; 25(2):136-43. PubMed ID: 15875906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
